Biomerica (BMRA) Net Cash Flow Growth (5y) (2015 - 2026)
Biomerica (BMRA) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.32 Bn | 177.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.65 Bn | 67.20 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.43 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.48 Bn | 26.19 Bn | 1.98 Bn |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.98 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -23.99% |
| Nov 30, 2025 | 16.83% |
| Aug 31, 2025 | 19.03% |
| May 31, 2025 | -16.07% |
| Feb 28, 2025 | -14.91% |
| Nov 30, 2024 | -81.22% |
| Aug 31, 2024 | -66.56% |
| May 31, 2024 | -36.17% |
| Feb 29, 2024 | -54.65% |
| Nov 30, 2023 | -28.95% |
| Aug 31, 2023 | -22.88% |
| May 31, 2023 | 59.79% |
| Feb 28, 2023 | -50.68% |
| Nov 30, 2022 | -31.04% |
| Aug 31, 2022 | 26.12% |
| May 31, 2022 | -68.21% |
| Feb 28, 2022 | 114.14% |
| Nov 30, 2021 | -53.58% |
| Aug 31, 2021 | 67.44% |
| May 31, 2021 | -24.93% |